Sei Investments CO Lannett CO Inc Transaction History

Sei Investments CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$3.43 - $6.19 $854 - $1,541	-249 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$4.75 - $14.5 $6,051 - $18,473	-1,274 Reduced 83.65%	249 $0
Q2 2018 Aug 03, 2018	BUY	$13.3 - $17.45 $3,724 - $4,886	280 Added 22.53%	1,523 $21,000
Q1 2018 May 11, 2018	SELL	$14.7 - $24.95 $2,969 - $5,039	-202 Reduced 13.98%	1,243 $20,000
Q4 2017 Feb 08, 2018	SELL	$19.9 - $29.25 $8,676 - $12,753	-436 Reduced 23.18%	1,445 $34,000
Q3 2017 Nov 06, 2017	BUY	$15.1 - $19.25 $28,403 - $36,209	1,881	1,881 $35,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.